Ahn Jae-yong, left, CEO of SK bioscience, poses with Thomas Triomphe, executive vice president of Sanofi, during the Vaccines Investor Event hosted by Sanofi in London, June 29. The two companies announced the successful completion of the Phase 2 clinical trial of a pneumococcal vaccine that they are jointly developing.…Read More
SK bioscience completes Phase 2 trial for pneumococcal vaccine
